Publication details
Pay-for-delay dohody ve farmacii: když restriktivní přístup k cílovým dohodám není až tak restriktivní
| Title in English | Pay-for-delay agreements in pharmaceuticals: when restrictive approach to "by object" agreements is not so restrictive after all |
|---|---|
| Authors | |
| Year of publication | 2018 |
| Type | Article in Periodical |
| Magazine / Source | Antitrust |
| MU Faculty or unit | |
| Citation | |
| Web | Repozitář MU |
| Keywords | pay-for-delay; pharmaceuticals; antitrust; competition law |
| Attached files | |
| Description | Relevant pay-for-delay agreements for competition law are primarily those entered into by pharmaceutical companies as settlement agreements in the context of patent litigations. Competition authorities consider the agreements as anticompetitive by object. Such an understanding of the agreements is however disputable. Couple of CJEU's decisions expected in near future may change this view. |
| Related projects: |